Paradoxical poor prognosis of myeloma patients who demonstrate complete healing of bone lesions following treatment
Wulfeck, D.W.; Williams, T.E.
Journal of the Kentucky Medical Association 92(4): 136-139
1994
ISSN/ISBN: 0023-0294 PMID: 8006500 Document Number: 429265
Multiple myeloma is the most common primary malignant bone neoplasm in adults, primarily over the age of 40. The most common radiographic findings include osteopenia, lytic lesions, and pathologic fractures. Although marked bone repair and healing can occur following therapy, this is often, paradoxically, a poor prognostic indicator.
Document emailed within 1 workday
Related Documents
Arnold, F.; O'Brien, J.; Cherry, G. 1995: Granulocyte monocyte-colony stimulating factor as an agent for wound healing. a study evaluating the use of local injections of a genetically engineered growth factor in the management of wounds with a poor healing prognosis Journal of Wound Care 4(9): 400-402Yoh, S.; Takagishi, N. 1988: Intra-arterial high-dose adriamycin in patients with malignant bone or soft tissue tumors. the factors in poor prognosis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(8 Part 2): 2453-2458
Kamani, N.; August, C.S.; Bunin, N.; Leahey, A.; Bayever, E.; Goldwein, J.; Zusman, J.; Evans, A.E.; Angio, G.D. 1996: A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma Bone Marrow Transplantation 17(6): 911-916
Shetty, K.; Bouquot, J. 2009: Residual (ghost) sockets in bisphosphonate use--evidence of poor healing and slow bone turnover General Dentistry 57(2): 130-135
Hata, H.; Mitsuya, H. 2006: Management of bone lesions in multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(8): 1072-1076
Orlando, R.; Pelizzo, M.Rosa.; Lirussi, F. 2003: Adrenocortical carcinoma: a 15-year survival after complete resection and repeated resection. A retrospective study in a patient with an expected poor prognosis Anticancer Research 23(3c): 2929-2931
Seeger, R.C.; Villablanca, J.G.; Matthay, K.K.; Harris, R.; Moss, T.J.; Feig, S.A.; Selch, M.; Ramsay, N.; Reynolds, C.P. 1991: Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma Progress in Clinical and Biological Research 366: 527-533
Vagner-Capodano, A.M.; Michel, G.; Maraninchi, D.; Tubiana, N.; Gouzien, M.; Perrimond, H.; Carcassonne, Y. 1988: Poor prognosis of acute lymphoblastic leukemia with translocation (1;19) in childhood: potential interest of allogeneic bone marrow transplantation Annales de Genetique 31(1): 53-56
Ceneli, O.; Haznedar, R. 2008: Advanced multiple myeloma with negative bone marrow biopsy and positive soft tissue lesions in the (18)F-FDG PET/CT scan Hellenic Journal of Nuclear Medicine 11(1): 56-57
Rosen, L.S.; Gordon, D.; Kaminski, M.; Howell, A.; Belch, A.; Mackey, J.; Apffelstaedt, J.; Hussein, M.; Coleman, R.E.; Reitsma, D.J.; Seaman, J.J.; Chen, B.L.; Ambros, Y. 2001: Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial Cancer Journal 7(5): 377-387
Kantarjian, H.M.; Keating, M.J.; McCredie, K.B.; Walters, R.; Talpaz, M.; Smith, T.L.; Freireich, E.J. 1987: Old age: a sign of poor prognosis in patients with chronic myelogenous leukemia Southern Medical Journal 80(10): 1228-1232
Bai, Q-L.; Hu, C-W.; Wang, X-R.; Yin, G-F.; Shang, J-X. 2017: Association between downexpression of miR-1301 and poor prognosis in patients with glioma European Review for Medical and Pharmacological Sciences 21(19): 4298-4303
Abou-Mourad, N.N.; Chamberlain, B.E.; Ackerman, N.B. 1979: Poor prognosis of patients with intra-abdominal sepsis and hypouricemia Surgery Gynecology and Obstetrics 148(3): 358-360
Bladé, J. 1988: Multiple myeloma and idiopathic monoclonal gammapathy. Diagnosis, prognosis and treatment Medicina Clinica 90(17): 704-714
Longree, L.; Focan, C.; Dallemagne, B.; Delforge, M.; Jehaes, C.; Malherbe, R.; Mazy, V.; Markiewicz, S.; Weerts, J.; Lombard, R. 1992: Tolerance of adjuvant treatment combining postoperative intraportal chemotherapy and a systemic treatment based on 5-fluorouracil in colorectal carcinoma with a histologically poor prognosis Acta Gastro-Enterologica Belgica 55(4): 341-349
Daly, K.; Hutchinson, S.; McCollum, C. 2003: Etiology of mental status changes in patients after total hip arthroplasty: hypoxemia or paradoxical embolization of fat or bone marrow? Journal of Bone and Joint Surgery. American Volume 85(5): 967; Author Reply 967
Krzymański, G. 1988: Application of complex grafts of autogenic bone marrow and allogenic lyophilized bone in fracture and mandible defect delayed healing treatment Czasopismo Stomatologiczne 41(8): 494-502
Umbas, R.; Isaacs, W.B.; Bringuier, P.P.; Schaafsma, H.E.; Karthaus, H.F.; Oosterhof, G.O.; Debruyne, F.M.; Schalken, J.A. 1994: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer Cancer Research 54(14): 3929-3933
Oishi, T.; Kimura, K.; Hanada, M.; Samejima, M. 1982: Assistance extended to patients with poor prognosis and their families--a lesson in role playing Nursing Technique 28(16): 2183-2188
Darskaia, E.I.; Zubarovskaia, L.S.; Afanas'ev, B.V. 1999: Administration of liposomal preparation of Dauno Xome for breast cancer in patients with poor prognosis Voprosy Onkologii 45(4): 440-444